Repligen Corporation, a life sciences company focused on bioprocessing technology, appointed Jason Garland chief financial officer, effective September 25, 2023. He succeeds retiring CFO Jon Snodgres. Garland is joining Repligen from his most recent role with Integer Holdings Corp., where he served for nearly five years as executive vice president and CFO. In his new role, Garland will act as a key partner to the business, with responsibility for all corporate finance and audit functions, ...